Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer

Breast Cancer Research and Treatment

Volumn 130, Issue 1, 2011, Pages 319-329

  Huang, Katie T ^a,b   Takano, Elena A ^a   Mikeska, Thomas ^a,b   Byrne, David J ^a   Dobrovic, Alexander ^a,b   Fox, Stephen B ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Breast cancer; CITED4; DNA methylation; HIF

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CBP P300 INTERACTING TRANSACTIVATOR WITH ED RICH CARBOXY TERMINAL DOMAIN 4; GLUCOSE TRANSPORTER 1; HISTONE DEACETYLASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; HIGH RESOLUTION MELTING ANALYSIS; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MUTATION RATE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION; TUMOR CELL LINE;

ANOXIA; AZACITIDINE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HCT116 CELLS; HL-60 CELLS; HUMANS; HYDROXAMIC ACIDS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; K562 CELLS; MUTATION; NEOPLASM INVASIVENESS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 82455162361     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1657-1     Document Type: Article

References (22)

1. Bos R, Zhong H, Hanrahan CF et al (2001) Levels of hypoxiainducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93(4):309-314 (Pubitemid 32219818)
2. Yamamoto Y, Ibusuki M, Okumura Y et al (2008) Hypoxiainducible factor 1 alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat 110(3):465-475 (Pubitemid 351962589)
3. Dales JP, Garcia S, Meunier-Carpentier S et al (2005) Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer 116(5):734-739 (Pubitemid 41099705)
4. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38-47 (Pubitemid 37328806)
5. Patiar S, Harris AL (2006) Role of hypoxia-inducible factor-1 alpha as a cancer therapy target. Endocr Relat Cancer 13: S61- S75 (Pubitemid 46219249)
6. Arany Z, Huang LE, Eckner R et al (1996) An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93(23):12969-12973 (Pubitemid 26382753)
7. Fox SB, Braganca J, Turley H et al (2004) CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha. Cancer Res 64(17):6075-6081 (Pubitemid 39129407)
8. Braganca J, Swingler T, Marques FI et al (2002) Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2. J Biol Chem 277(10):8559-8565 (Pubitemid 34968320)
9. Bhattacharya S, Michels CL, Leung MK et al (1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 13(1):64-75 (Pubitemid 29045116)
10. Huang KT, Mikeska T, Dobrovic A et al (2010) DNA methylation analysis of the HIF-1alpha prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas. Histopathology 57(3):451-460
11. Wojdacz TK, Dobrovic A (2007) Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucl Acids Res 35(6): e41
12. Wojdacz TK, Hansen LL, Dobrovic A (2008) A new approach to primer design for the control of PCR bias in methylation studies. BMC Res Notes 1:54
13. Tews B, Roerig P, Hartmann C et al (2007) Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene 26(34):5010-5016 (Pubitemid 47172644)
14. Candiloro IL, Mikeska T, Hokland P et al (2008) Rapid analysis of heterogeneously methylated DNA using digital methylationsensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenet Chromatin 1(1):7
15. Nolan T, Hands RE, Bustin SA (2006) Quantification of mRNA using real-time RT-PCR. Nat Protoc 1(3):1559-1582
16. Mikeska T, Dobrovic A (2009) Validation of a primer optimisation matrix to improve the performance of reverse transcription-quantitative real-time PCR assays. BMC Res Notes 2:112
17. Rasmussen R (2001) Rapid cycle real-time PCR. In: Meuer S, Wittwer C, Nakagawara K (eds) Methods and applications. Springer, Heidelberg, pp 21-34
18. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29(9): e45
19. Vandesompele J, De Preter K, Pattyn F et al (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7): RESEARCH0034.1-RESEARCH0034.12
20. Cameron EE, Bachman KE, Myohanen S et al (1999) Synergy of demethylation and histone deacetylase inhibition in the reexpression of genes silenced in cancer. Nat Genet 21(1):103-107 (Pubitemid 29036293)
21. Torres-Martin M, Franco-Hernandez C, Martinez-Glez V et al (2008) Mutational analysis of the CITED4 gene in glioblastomas. Cancer Genet Cytogenet 185(2):114-116
22. Suzuki H, Gabrielson E, Chen W et al (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31(2):141-149